Drugs / TMTP1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03321461 | Nov 2017 → Aug 2020 | cervical intraepithelial neoplasia | Huazhong University of Science and Technology | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMTP1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03321461 ↗ |
| Modality | Diagnostic / imaging agent | “Novel Tumor Targeted Fluorescent TMTP1-ICG Mapping in Colposcopy-directed Biopsy” NCT03321461 ↗ |
| Route | Topical | “Then TMTP1-ICG spray was applied thoroughly to the ectocervix for 30 minutes.” NCT03321461 ↗ |